GENNEX Quarterly Results, Profit & Loss, Balance Sheet (GENNEX) GENNEX quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Gennex Laboratories Ltd (GENNEX) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Gennex Laboratories Ltd reported sales of ₹39.84 Cr, operating profit of ₹4.38 Cr (OPM 10.99%) and net profit of ₹4.67 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
GENNEX quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 33.38 40.01 40.33 34.18 39.3 42.96 60.96 39.84 Expenses 25.92 32.86 38.31 29.11 31.74 34.39 55.07 35.46 Operating Profit 7.46 7.15 2.02 5.07 7.56 8.57 5.89 4.38 OPM 22.35% 17.87% 5.01% 14.83% 19.24% 19.95% 9.66% 10.99% Other Income 0 0 3.68 2.28 0 -0.3 1.02 2.01 Interest 0.22 0.84 1.2 0.98 1.03 1.11 1.08 0.57 Depreciation 1.11 0.5 0.54 0.5 0.47 0.52 1.16 0.9 Profit before tax 6.13 5.81 3.96 5.87 6.06 6.64 4.67 4.92 Tax 12.23% 12.91% 22.22% 14.48% 9.08% 9.79% 4.5% 5.08% Net Profit 5.38 5.06 3.07 5.01 5.51 6 4.46 4.67 EPS in Rs 0.21 0.2 0.1 0.2 0.21 0.22 0.15 0.18
GENNEX profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 61 66 87 138 173 183 Expenses 56 61 70 121 150 157 Operating Profit 5 5 17 17 22 26 OPM 9% 7% 20% 12% 13% 14% Other Income 1 4 5 10 8 3 Interest 1 1 3 4 4 4 Depreciation 1 1 2 2 3 3 Profit before tax 5 6 16 21 23 22 Tax 23% 23% 20% 15% 10% - Net Profit 4 5 13 18 21 21 EPS in Rs 0.21 0.28 0.58 0.8 0.76 0.76 Dividend Payout 0% 0% 0% 0% 0% -
GENNEX balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 18 23 23 24 24 Reserves 62 148 164 189 198 Borrowings 1 6 10 88 79 Other Liabilities 51 54 59 55 47 Total Liabilities 132 230 256 357 349 Fixed Assets 74 56 60 76 61 CWIP 0 2 5 0 13 Investments 0 0 0 0 0 Other Assets 59 172 191 281 275 Total Assets 132 230 256 357 349
GENNEX cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 12 24 -47 -11 -64 Cash from Investing Activity -2 -38 19 1 -5 Cash from Financing Activity -2 21 74 5 65 Net Cash Flow 8 6 46 -5 -3 Free Cash Flow 10 -16 -31 -20 -76 CFO/OP 242% 505% -274% -45% -274%
GENNEX ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 67 52 75 37 92 Inventory Days 72 139 184 133 153 Days Payable 72 63 111 49 58 Cash Conversion Cycle 67 129 148 122 187 Working Capital Days 87 23 255 214 295 ROCE 12% 11% 14% 13% 11%